1094091-46-9 Usage
Uses
Used in Pharmaceutical Industry:
Imidazo[1,5-a]pyrazine-1,7(8H)-dicarboxylic acid, 3-bromo-5,6-dihydro-, 7-(1,1-dimethylethyl) ester is used as a pharmaceutical intermediate for the development of new drugs. Its unique structure and properties make it a promising candidate for the synthesis of novel therapeutic agents.
Used in Medicinal Chemistry Research:
Imidazo[1,5-a]pyrazine-1,7(8H)-dicarboxylic acid, 3-bromo-5,6-dihydro-, 7-(1,1-dimethylethyl) ester is used as a research compound in medicinal chemistry. Its unique structure and properties allow scientists to explore its potential as a lead compound for the development of new drugs and therapeutic agents.
Used in Drug Discovery:
Imidazo[1,5-a]pyrazine-1,7(8H)-dicarboxylic acid, 3-bromo-5,6-dihydro-, 7-(1,1-dimethylethyl) ester is used in drug discovery processes to identify potential drug candidates. Its unique structure and properties make it an interesting compound for further studies and optimization to develop new therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 1094091-46-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,9,4,0,9 and 1 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1094091-46:
(9*1)+(8*0)+(7*9)+(6*4)+(5*0)+(4*9)+(3*1)+(2*4)+(1*6)=149
149 % 10 = 9
So 1094091-46-9 is a valid CAS Registry Number.
1094091-46-9Relevant academic research and scientific papers
INHIBITORS OF MUTANT ISOCITRATE DEHYDROGENASES AND COMPOSITIONS AND METHODS THEREOF
-
, (2019/02/13)
The invention provides novel chemical compounds useful for treating cancer, or a related disease or disorder thereof, and pharmaceutical composition and methods of preparation and use thereof.
SUBSTITUTED IMIDAZOHETEROCYCLES
-
Page/Page column 17; 18, (2009/01/24)
The present invention provides substituted imidazoheterocyclic compounds having the structure of formula I Also provided are pharmaceutically acceptable salts, acid salts, hydrates, solvates and stereoisomers of the compounds of formula I. The compounds are useful as modulators of cannabinoid receptors and for the prophylaxis and treatment of cannabinoid receptor-associated diseases and conditions, such as pain, inflammation and pruritis.
